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Abstract 
Background: The meta-analysis was performed to evaluate the effect of dissection 
and re-entry (DR) vs. wire escalation (WE) techniques on long-term clinical outcomes 
in patients with chronic total occlusion (CTO) lesions undergoing percutaneous 
coronary intervention (PCI). 
Methods: Studies were searched in electronic databases from inception to September, 
2019. Results were pooled using random effects model and fixed effects model and 
are presented as risk ratios (RR) with 95% confidence intervals (CI). 
Results: Pooled analyses revealed that patients with DR techniques had overall higher 
complexity CTO lesions than patients with WE techniques and required a greater 
number of stents and a greater mean stent length. The “extensive” DR techniques may 
have a higher incidence of target vessel revascularization (TVR) (RR = 2.30, 95% CI: 
1.77–2.98), in-stent restenosis (RR = 1.71, 95% CI: 1.30–2.23), in-stent reocclusion 
(RR = 1.86, 95% CI: 1.03–3.3) and death/MI/TVR (RR = 2.10, 95% CI: 1.71–2.58), 
when compared with WE techniques, during the long-term follow-up. However, 
“limited” DR techniques result in more promising outcomes, and are comparable to 
conventional WE techniques.  
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Conclusions: Dissection and re-entry techniques were associated with increased risk 
of long-term negative clinical events, especially “extensive” DR techniques. However, 
“limited” DR techniques resulted in good long-term outcomes, comparable to WE 
techniques.  
Key words: chronic total occlusion, percutaneous coronary intervention, 
dissection and re-entry, wire escalation, meta-analysis 
 
 
Introduction 
In the hybrid algorithm to chronic total occlusion (CTO) percutaneous coronary 
intervention (PCI), dissection and re-entry (DR) by either the antegrade or the 
retrograde approach has since evolved to an indispensable strategy for crossing the 
occlusion, and this has contributed in improving the technical success rate of CTO 
PCI, when compared to conventional wire escalation (WE) techniques, especially for 
complex lesions [1]. However, the long-term prognosis of patients with DR 
techniques remains controversial. Some concerns have been raised on the possible 
increased risk of a higher incidence of restenosis, while other concerns support the 
potential role of DR in the contemporary CTO PCI, when compared to a conventional 
true-to-true (TTT) lumen strategy [2, 3]. Furthermore, positive improvements have 
already been made with the development of new and better materials and equipment, 
such as device-based “controlled” antegrade DR (ADR) and retrograde DR (RDR) 
[4]. However, it remains unknown whether this can further improve the prognosis of 
patients. Although there has been a meta-analysis on the subject so far [5]. Moreover, 
many additional cohort studies have been published since. Therefore, a 
comprehensive updated meta-analysis is warranted. Therefore, the present meta-
analysis was conducted to evaluate the impact of DR vs. WE techniques on long-term 
clinical outcomes in patients undergoing CTO PCI. 
 
Methods 
Search strategy 
Eligible trials were identified by performing electronic searches on PubMed, 
Embase, Web of Science, and the Cochrane Central Register of Controlled Trials 
(CENTRAL) using the following search items: “chronic total occlusion” or “CTO” 
AND “subintimal” OR “subadventitial” OR “dissection” OR “tracking” OR “re-
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entry” OR “CART” OR “controlled antegrade and retrograde tracking” OR “STAR” 
OR “subintimal tracking and re-entry” OR “LAST” OR “limited antegrade subintimal 
tracking” OR “CrossBoss and Stingray” OR “Boston Scientific” OR “wire escalation” 
OR “intraplaque” OR “intimal” OR “true-to-true” OR “crossing”. was provided in the 
supplementary data. The inclusion period was from the establishment of the databases 
to September 2019. YJZ and HYP independently performed the literature search, and 
any differences were resolved by discussion. 
 
Study selection 
Studies were included when the following were satisfied: (1) studies that directly 
compared the clinical outcomes of all-cause death, cardiac death, myocardial 
infarction (MI), target vessel revascularization (TVR), in-stent restenosis (ISR), in-
stent occlusion (ISO) or stent thrombosis (ST), during the follow-up period, after the 
successful recanalization of CTO lesions. using the DR technique vs. WE technique is 
directly made; (2) observational studies and randomized controlled trials (RCTs) 
published as original articles.  
 
Data extraction and quality assessment 
Data were extracted by one reviewer (YJZ) and independently checked by 
another two reviewers (HYP and XNL). Any disagreements between the reviewers 
were resolved by discussion with a fourth investigator (JHL), and by referencing the 
original report. The quality of the cohort study was assessed using the Newcastle-
Ottawa scale. A study was regarded as high-quality when it was awarded a total score 
of ≥ 6 in the Newcastle-Ottawa scale [6, 7]. 
 
Statistical analysis 
For dichotomous data, the available risk estimates extracted were mostly rate 
ratios (RRs), while those in partial studies were hazard ratios (HRs), incidence rate 
ratios (IRRs), or odds ratios (ORs). When risk estimates and confidence intervals 
(CIs) were not provided, the RRs and CIs were calculated from the available data 
using the Woolf method in the Stata version 15.0 software. For continuous data, 
standard mean differences (SMD) and the corresponding 95% CIs were pooled to 
compare the continuous outcomes between the two groups [8, 9]. Heterogeneity 
across studies was determined using the I2 statistic, which is a quantitative measure of 
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inconsistency across studies. The following criteria was used: I2 < 50%: low 
heterogeneity; I2 = 50–75%: moderate heterogeneity and I2 > 75%: high 
heterogeneity. The heterogeneity was considered significant when the 2 test was 
significant (p < 0.10) or the I2 was > 50% [9, 10]. The analysis was performed with 
random effects models at first, then further changed to the fixed effects models to 
calculate the RR and 95% CIs again to avoid interferences from small sample studies. 
The sensitivity was determined to evaluate the stability of the present results by 
removing each study one at a time (metaninf command). What is more, subgroup 
analyses stratified according to different approaches (anterograde or retrograde), 
different DR techniques (“limited DR” or “extensive DR”) and different areas (Asia, 
Europe or America) were performed to explore potential sources of heterogeneity in 
outcomes (metan command). The “extensive DR” techniques were as follows: (1) 
subintimal tracking and re-entry (STAR, including mini-STAR and contrast-guided 
STAR); (2) limited antegrade subintimal tracking (LAST) for the antegrade approach; 
(3) controlled antegrade and retrograde tracking (CART) for the retrograde approach. 
The “limited DR” techniques were as follows: (1) reverse CART for the retrograde 
approach; (2) device-facilitated techniques (using the CrossBoss/Stingray system; 
Boston Scientific, Marlborough, MA) [11]. For dichotomous data, publication bias 
was assessed by Harbord’s regression asymmetry test [12]. For continuous data, 
publication bias was assessed by the Egger regression asymmetry test [13]. The 
statistical tests were two-sided, and a significance level of p < 0.05 was used. 
 
Results 
Literature search and quality assessment 
A total of 2,588 studies were identified through the electronic searches, and 561 
were excluded due to duplication. Then, 2,027 studies were also excluded after 
reading the titles and abstracts. The remaining 65 studies were assessed by reading the 
full texts. Eventually, 12 cohort studies were included in qualitative synthesis and 
meta-analysis [11, 14–24]. The flow diagram of the study selection process is 
presented in Figure 1. The characteristics of the included studies are summarized in 
Supplementary Table S1. The quality of cohort studies assessed with the Newcastle-
Ottawa scale were summarized in Supplementary Table S2. All included studies 
were of high quality, as determined by a Newcastle-Ottawa scale score of ≥ 6 for 
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cohort studies. 
 
Long-term outcomes 
Mortality 
All-cause mortality. The outcome occurred in at least 76 events among the 3,166 
participants from nine cohort studies [14–19, 21, 22, 24]. The pooled RR value of all-
cause mortality in the DR technique group, when compared with that in the 
conventional WE technique group, was 1.52 (95% CI: 0.95–2.45; Fig. 2A), and there 
was no heterogeneity (I2 = 0.0%, p = 0.858).  
Cardiovascular mortality. Nine cohort studies (3,164 patients) reported this outcome 
[11, 14, 16-20, 22, 24], and no heterogeneity was found among these trials (I2 = 
0.00%, p = 0.637; Fig. 2B). The results were RR = 0.97 and 95% CI: 0.52–1.81, 
indicating no statistical differences. 
 
Myocardial infarction  
Ten cohort studies were included for the outcome, which involved 4,090 
participants and 97 events, and no heterogeneity was found for MI incidence (I2 = 
0.00%, p = 0.890; Fig. 2C) [11, 14–19, 21, 22, 24]. The pooled results indicated that 
DR technique in CTO PCI may have a higher incidence of MI, when compared with 
the conventional WE technique, during long-term follow-up (RR = 1.59, 95% CI: 
1.06–2.40; Fig. 2C). 
 
Target vessel revascularization  
Eleven studies with 4,260 patients were included, and low heterogeneity was 
found (I2 = 26.50%, p = 0.192; Fig. 2D) [11, 14–22, 24]. The data revealed significant 
differences between the two groups with regard to TVR (RR = 1.61, 95% CI: 1.29–
2.01; Fig. 2D). Compared with the conventional WE strategy, successful CTO PCI 
after DR crossing was associated with a higher rate of TVR in long-term follow-up. 
 
Composite outcomes: Death/MI/TVR 
The incidence of composite outcomes was 15.35% (n = 234) in the DR technique 
group and 13.58% (n = 480) in the WE technique group [11, 14–24]. There was a 
significantly higher incidence of death/MI/TVR in the DR technique group, when 
compared with that in the WE technique group (RR = 1.54, 95% CI: 1.27–1.87; Fig. 
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2E). There was a low heterogeneity among these trials (I2 = 30.9%, p = 0.144; Fig. 
2E). 
 
In-stent restenosis, reocclusion and thrombosis  
The pooled outcomes revealed that the DR technique in CTO PCI was associated 
with higher rates of ISR (RR = 1.62, 95% CI: 1.26–2.10; I2 = 0.0%, p = 0.459; 
Fig.3A) and in-stent reocclusion (RR = 1.90, 95% CI: 1.09–3.31; I2 = 0.00%, p = 
0.891; Fig. 3B) [16, 19, 22, 24]. As shown in Figure 3C, no significant difference in 
stent thrombosis was observed during follow-up after successful CTO PCI between 
the DR technique and WE technique (RR = 1.59, 95% CI: 0.64–3.93; I2 = 0.00%, p = 
0.733) [14, 16–19, 22, 24].  
 
Procedural characteristics in the real world 
CTO occlusion length and J-CTO score 
The CTO length was significantly longer in patients with subintimal DR 
techniques, when compared with conventional WE crossing (SMD: 0.64, 95% CI: 
0.31–0.97, p < 0.001; I2 = 83.4%, p < 0.001; Fig. 3D) [14, 16, 17, 19, 21]. 
Furthermore, patients with DR techniques had an overall higher complexity of CTO 
lesions than patients with WE techniques, which was evidenced by the J-CTO score 
(SMD: 0.90, 95% CI: 0.68–1.12, p < 0.001; I2 = 79.4%, p < 0.001; Fig. 3E) [11, 14, 
17, 20, 21]. 
 
Stent length and number of stents 
Stent length were recorded by 9 cohort studies [11, 14, 16–22], while the number 
of stents were recorded by 7 cohort studies [14, 16, 18–20, 22, 24]. CTO PCI with DR 
tracking required a greater number of stents (SMD: 0.57, 95% CI: 0.49–0.66, p < 
0.001; I2 = 66.0%, p < 0.001; Fig. 3G) and a greater mean stent length (SMD: 0.80, 
95% CI: 0.73-0.86, p < 0.001; I2 = 59.1%, p = 0.007; Fig. 3F), when compared to WE 
tracking. 
 
Subgroup analysis for long-term outcomes  
Predefined subgroup analyses were conducted across key study characteristics 
summarized in Table 1. Specifically, the intension was to conduct subgroup analyses 
by different approaches and different DR techniques to clarify whether patients with 
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retrograde approach and “extensive/old” DR techniques were at particularly high 
cardiovascular risk. In the subgroup analyses by different approaches,  no differences 
were found between the anterograde approach and retrograde approach in CTO PCI. 
However, there were significant statistical differences in the long-term clinical 
outcomes between “limited/new” DR techniques and “extensive/old” DR techniques. 
Subgroup analysis indicated that the use of “extensive” DR techniques was associated 
with higher risk of TVR (RR = 2.30, 95% CI: 1.77–2.98; Table 1), ISR (RR = 1.71, 
95% CI: 1.30–2.23; Table 1), in-stent occlusion (RR = 1.86, 95% CI: 1.03–3.38; Table 
1) and composite endpoints (RR = 2.10, 95% CI: 1.71–2.58; Table 1), while “limited” 
DR techniques did not higher the cardiovascular risk, when compared with WE 
techniques. Besides, considering different technologies in CTO PCI applied in 
different areas, subgroup analyses was conducted by different areas. The results 
showed that the incidence of MACCE with DR techniques in studies from Europe was 
reported higher than that of others (Table 1). 
 
Sensitivity analysis 
In sensitivity analysis, risk estimates all slightly changed after analysis while 
removing a study for all outcomes, indicating the robustness of the present findings, 
and that no single study drove the summary effects (Fig. 4). 
 
Publication bias 
The Harbord regression test suggested no obvious publication bias for all binary 
outcomes, as shown in Figure 5. The Egger regression test suggested no obvious 
publication bias for J-CTO score, stent length, and number of stents. However, a 
significant publication bias for the outcome of CTO occlusion length was detected 
using the Egger regression test (p = 0.048, Fig. 5I). The conclusion did not change 
after adjustment for publication bias using the trim and fill method. 
 
Discussion 
According to available research, this is the latest and largest meta-analysis 
reported to date on the effect of DR techniques vs. conventional WE techniques on 
long-term clinical outcomes in CTO PCI, which included 5,265 participants from 12 
cohort studies. With accumulating evidence, the statistical power was enhanced to 
provide more precise and reliable risk estimates. The most-relevant heterogeneity 
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moderators have been identified by subgroup analyses. The sensitivity analysis and 
publication bias were performed to ensure the stability of the present results. The 
following are the main findings of the present meta-analysis:  
— The application of DR techniques in CTO PCI is associated with similar risk of 
mortality, but with higher risk of MI, TVR, ISR and in-stent re-occlusion, when 
compared with WE techniques, during clinical follow-up of 12–24 months.  
— DR techniques were more applied in patients with higher complexity CTO lesions, 
which was evidenced by higher J-CTO score and longer CTO occlusion length. 
Therefore, CTO PCI with DR tracking required a greater number of stents and longer 
stent length, that may explain the higher incidence of long-term adverse 
cardiovascular events in the DR techniques group as compared with WE techniques. 
— Furthermore, extensive DR techniques raises the risk of long-term clinical adverse 
events. However, limited DR techniques for crossing CTO was associated with similar 
long-term MACE, as compared to WE crossing, highlighting the growing role of 
more controlled subintimal crossing technique utilization in achieving high procedural 
success.  
The recanalization of coronary occlusion lesions remains one of the major 
challenges in interventional cardiology. Conventional WE techniques typically use an 
intraplaque course for CTO crossing. DR techniques exploit the subintimal space for 
coronary wire passage with subsequent re-entry into the true lumen, which is needed 
more often to obtain success, when compared to antegrade and/or retrograde wiring 
strategies, especially for treating higher complexity CTO lesions. With the positive 
improvement and development of dedicated equipment, DR techniques have since 
evolved to an indispensable strategy of contemporary CTO PCI [25]. According to 
previous reports, the frequency of subintimal tracking ranges from 8.7% to 45.5% in 
the antegrade approach, and from 24.2% to 50.0% in the retrograde approach [18]. 
Although DR strategies have been increasingly adopted, controversial data regarding 
long-term clinical prognosis of DR techniques have been published in this area, 
prompting the investigators to conducted the present meta-analysis to evaluate the 
long-term clinical outcomes of DR techniques, when compared to conventional WE 
techniques. 
The findings of the present analysis indicated that DR techniques may increase 
the incidence of MI, TVR and ISR in patients with successful CTO PCI, when 
compared to a conventional WE strategy. Both ADR and RDR involves dissection and 
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subsequent stenting within the subintimal space. A previous intravascular ultrasound 
(IVUS) reported that subintimal stenting could disturb the vessel geometry, which 
may lead to late acquired malposition and microaneurysms, stent thrombosis, and re-
occlusion [26–28]. Furthermore, the present meta-analysis showed that the overall 
higher risks of TVR and ISR with DR techniques could also be partially explained by 
the greater number of stents and longer stent length after subintimal tracking in CTO 
PCI. The impact of total stent length on long-term clinical outcomes has been reported 
[29]. In brief, the main reason for the negative clinical impact was not only the 
subintimal wire tracking itself but also the greater number and longer stent 
requirement.  
It was found in the present meta-analysis that early subintimal DR strategies 
were associated with a greater risk of adverse events, which were mainly almost two-
fold higher rates of TVR and ISR, when compared with WE techniques, during 
clinical follow-up of 12–24 months. Since the first application of STAR in 2005, 
continuous improvements have been made including mini-STAR, LAST for 
antegrade, and the CART technique for retrograde subintimal revascularization [30–
33]. These early subintimal techniques pose a higher risk of subintimal hematoma 
formation and extensive dissection, causing a side-branch vessel occlusion to occur, 
potentially limiting distal outflow, and predisposing high TVR risk. Thus, this would 
further result in negative clinical events. Meanwhile, the disappointing clinical 
outcomes were also due to the unnecessary longer stent lengths, greater numbers of 
stents, as well as compression of the distal lumen with consequent under sizing of 
stents. Nevertheless, data regarding the outcomes with modern DR techniques were 
much more promising, indicating that neither TVR, nor the ISR rates, were increased 
by modern subintimal strategies, when compared to conventional WE crossing, from 
the present meta-analysis. Both the “new” ADR and “new” RDR involved proper 
wiring techniques and available equipment to minimize the subintimal space, 
potentially lowering the risks for TVR or ISR. In contemporary ADR, the dedicated 
CrossBoss and Stingray system (Boston Scientific, Natick, MA, USA) has the 
advantage of creating a safe and controlled antegrade dissection in the subintimal 
space, and a geographically precise and predictable successful re-entry [34]. In 
contemporary RDR, the subintimal space within the CTO segment is created by 
ballooning from antegrade direction (rCART), thereby limiting the length of 
dissection [35]. As a result, the present data provides evidence that support the 
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application of limited DR techniques in contemporary CTO PCI practice, even as a 
first-line strategy for DR. 
 
Limitations of the study 
There were some limitations in the present study. First, almost all the studies 
included in the present meta-analysis were observational studies, thereby making 
these susceptible to the effects of unidentified confounders. Thereby, RCTs should be 
performed in the future, in order to provide further support for the present results. 
Second, the intended crossing technique frequently does not frequently reflect the 
actual guidewire positioning, and this can be detected by IVUS [36, 37]. It has been 
previously reported that subintimal tracking occurs in approximately 50% of 
successful PCI cases, when carefully assessed by IVUS [38]. However, IVUS was 
utilized in only a minority of studies to differentiate the guidewire positioned in either 
the subintimal, or intimal. Hence, subintimal guidewire tracking is likely more 
common than expected in CTO-PCI practice, which may have affected the present 
results. 
 
Conclusions 
Dissection and re-entry techniques were applied more in patients with higher 
complexity CTO lesions and “extensive” DR techniques could increase the incidence 
of long-term negative clinical events. However, “limited” DR techniques resulted in 
good long-term outcomes, comparable to WE techniques, supporting the expanding 
use of more controlled DR techniques in contemporary CTO PCI practice. Further 
evidence from large RCTs is needed to define the optimal role of DR in hybrid CTO 
PCI. 
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Table 1. Subgroup and heterogeneity analyses of pooled risk ratios for long-term outcomes. 
  
Factors N (studies) Events/participants 
DR       WE 
RR (95% CI) I²  Pa 
MYOCARDIAL INFARCTION 
Different approaches  
Anterograde  4 15/252 14/894 1.93 (0.94–3.99) 0.0% 0.475 
Retrograde 5 2/261 3/322 0.45 (0.09–2.31) 0.0% 0.728 
Different DR techniques 
Extensive/Old DR techniques 3 7/195 19/957 1.79 (0.60–5.30) 32.4% 0.224 
Limited/New DR techniques 6 31/1120 29/2072 1.58 (0.93–2.71) 0.0% 0.657 
Location 
Asia 4 0/126 1/652 1.67 (0.07–40.52) - - 
Europe 4 30/1120 34/1862 1.47 (0.88–2.45) 0.0% 0.758 
America 2 21/167 11/163 1.86 (0.92–3.76) 0.0% 0.357 
TARGET VESSEL REVASCULARIZATION 
Different approaches  
Anterograde  4 34/252 65/894 1.19 (0.83–1.70) 0.0% 0.701 
 17 
Retrograde 5 34/263 49/324 1.23 (0.75–2.02) 24.6% 0.257 
Different DR techniques 
Extensive/Old DR techniques 3 62/197 115/959 2.30 (1.77–2.98) 3.1% 0.356 
Limited/New DR techniques 6 72/1120 106/2072 1.37 (0.97–1.94) 17.0% 0.304 
Location 
Asia 4 21/132 63/647 1.62 (1.04–2.52) 0.0% 0.688 
Europe 5 119/1193 142/1958 1.69 (1.19–2.40) 52.6% 0.077 
America 2 41/167 33/163 1.41 (0.68–2.93) 28.5% 0.237 
DEATH/MYOCARDIAL INFARCTION/TARGET VESSEL REVASCULARIZATION 
Different approaches  
Anterograde  3 18/219 61/871 1.22 (0.74–2.02) 0.0% 0.479 
Retrograde 4 31/264 59/525 1.17 (0.67–2.07) 43.8% 0.149 
Different DR techniques 
Extensive/Old DR techniques 4 83/229 316/1725 2.10 (1.71–2.58) 0.0% 0.658 
Limited/New DR techniques 6 114/1120 168/2072 1.24 (0.97–158) 5.1% 0.384 
Location 
Asia 4 20/130 74/645 1.40 (0.89–2.20) 0.0% 0.622 
Europe 6 175/1227 377/2726 1.61 (1.24–2.10) 54.7% 0.051 
America 2 39/167 29/163 1.40 (0.74–2.64) 45.8% 0.174 
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IN-STENT RESTENOSIS 
Different DR techniques 
Extensive/Old DR techniques 2 45/92 94/331 1.71 (1.30–2.23) 0.0% 0.588 
Limited/New DR techniques 1 4/22 13/100 1.40 (0.50–3.88) – – 
Location 
Asia 2 15/51 46/230 1.47 (0.91–2.39) 0.0% 0.910 
Europe 2 50/382 96/804 1.29 (0.61–2.71) 80.9% 0.022 
America 0 – – – – – 
IN-STENT OCCLUSION 
Different DR techniques 
Extensive/Old DR techniques 1 14/63 24/201 1.86 (1.03–3.38) – – 
Limited/New DR techniques 1 1/22 3/100 1.52 (0.17–13.89) – – 
Location 
Asia 2 2/35 6/220 2.17 (0.46–10.29) 0.0% 0.653 
Europe 1 14/63 24/201 1.86 (1.03–3.38) – – 
America 0 – – – – – 
aP value for heterogeneity; DR — dissection and re-entry; WE — wire escalation; IVUS — intravascular ultrasound; CTO — chronic total occlusion; PCI — 
percutaneous coronary intervention; RCT — randomized controlled trial; RR — risk ratio; CI — confidence interval
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Figure 1. Flow diagram of the study selection process. 
 
Figure 2. Forest plot for mortality, myocardial infarction (MI), target vessel 
revascularization (TVR) and composite outcomes (death/MI/TVR) in long-term 
follow-up. Forest plot demonstrates a pooled estimate of mortality during the follow-
up period: A. All-cause mortality; B. Cardiovascular mortality; C. Myocardial 
infarction; D. Target vessel revascularization; E. Death/MI/TVR. The risk ratio of 
each study along with a pooled risk ratio with 95% confidence intervals is depicted. 
 
Figure 3. Forest plot for in-stent restenosis, reocclusion, thrombosis in the long-term 
follow-up and the procedural characteristics of patients with chronic total occlusion 
(CTO). Forest plot demonstrating a pooled estimate of the following outcomes during 
the follow-up period: A. In-stent restenosis; B. In-stent reocclusion; C. Stent 
thrombosis. The risk ratio of each study along with a pooled risk ratio with 95% 
confidence intervals is depicted. 
 
Figure 4. Sensitivity analyses of pooled rate ratios for outcomes. Sensitivity analyses 
for the following outcomes: A. All-cause mortality; B. Cardiac mortality; C. 
Myocardial infarction (MI); D. Target vessel revascularization (TVR); E. 
Death/MI/TVR; F. In-stent restenosis; G. In-stent reocclusion; H. Stent thrombosis; I. 
Chronic total occlusion (CTO) occlusion length; J. J-CTO score; K. Stent length; L. 
Stent numbers. The risk ratio of each study along with a pooled risk ratio with 95% 
confidence intervals (CI) is depicted. The vertical lines in the middle represent the 
total combined effect of all the studies, and the left and right vertical lines represent 
the upper and lower limits of 95% CI of the total combined effect. The corresponding 
horizontal line for each study represents the combined effect of the remaining studies 
after deletion of the corresponding study. 
 
Figure 5. Publication bias plots of included studies. Publication bias of included 
studies for the following outcomes. A. All-cause mortality; B. Cardiac mortality; C. 
Myocardial infarction (MI); D. Target vessel revascularization (TVR); E. 
Death/MI/TVR; F. In-stent restenosis; G. In-stent reocclusion; H. Stent thrombosis; I. 
Chronic total occlusion (CTO) occlusion length; J. J-CTO score; K. Stent length; L. 
Stent numbers. 





